The Impact of Surfactant Composition and Surface Charge of Niosomes on the Oral Absorption of Repaglinide as a BCS II Model Drug
Morteza Yaghoobian,1 Azadeh Haeri,1 Noushin Bolourchian,1 Soraya Shahhosseni,2 Simin Dadashzadeh1,3 1Department of Pharmaceutics and Nanotechnology, School of Pharmacy, Shahid Beheshti University of Medical Sciences, Tehran, Iran; 2Department of Pharmaceutical Chemistry, School of Pharmacy, Shahid B...
Guardado en:
Autores principales: | Yaghoobian M, Haeri A, Bolourchian N, Shahhosseni S, Dadashzadeh S |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2020
|
Materias: | |
Acceso en línea: | https://doaj.org/article/81ae4bfac38e4f6c8fc20c5b94c53c21 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Correlation between Biophysical Properties of Niosomes Elaborated with Chloroquine and Different Tensioactives and Their Transfection Efficiency
por: Myriam Sainz-Ramos, et al.
Publicado: (2021) -
In vitro Characterization and Release Studies of Combined Nonionic Surfactant-Based Vesicles for the Prolonged Delivery of an Immunosuppressant Model Drug
por: Rasul A, et al.
Publicado: (2020) -
Short-term efficacy and safety of repaglinide versus glimepiride as augmentation of metformin in treating patients with type 2 diabetes mellitus
por: Xie J, et al.
Publicado: (2019) -
Repaglinide/metformin fixed-dose combination to improve glycemic control in patients with type 2 diabetes: an update
por: Moses R
Publicado: (2010) -
Iron oxide-doped niosomes as drug carriers for magnetically targeted drug delivery
por: Juneja R, et al.
Publicado: (2018)